Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
about
Biomarker development in MET-targeted therapyMET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysisPrognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literaturesElevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.c-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivoMEK inhibitors against MET-amplified non-small cell lung cancerDeveloping biomarkers to predict benefit from HGF/MET pathway inhibitors.Prognostic and predictive biomarkers in lung cancer. A review.Targeting the MET pathway for potential treatment of NSCLC.cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.Prognostic and predictive value of MET deregulation in non-small cell lung cancerAmplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.18F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma.Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome.Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib.Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.Clinical and prognostic significance of signal transducer and activator of transcription 3 and mucin 1 in patients with non-small cell lung cancer following surgery.KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancerSuppression of c-MET overcomes erlotinib resistance in tongue cancer cells
P2860
Q26751332-0DB1A9C6-42F6-4048-92AA-6433FB6CDAA7Q26823626-A09E458C-79CA-4B85-832A-E96FBBCF1864Q33748638-842FEF37-9A87-41C8-9EE4-8E10B439C82EQ36511748-B9606B56-1295-44D3-B431-0CE05DB16292Q36741686-DDB97724-460A-4E8C-B1D1-A992F8A6DFE0Q37427045-81EFC332-3DFA-4640-BD64-B129436525BFQ38150768-F12CE998-9414-4582-95C4-2740FE3EF637Q38178187-DBB30F03-AEEF-4DA0-B48B-523C50D3D029Q38297235-9B25B5E6-CD84-489E-853F-7307B8EB9283Q38393333-E0B43B54-74B3-4F79-B36A-C692CC7B88DFQ38493294-1267CAFC-3F0A-4F5C-A811-6316E8B3B3CAQ46562452-DD840647-B1B0-4E1C-8337-1293360595D7Q47146475-EDBC0FCE-42DB-46BF-BC8F-4D1351BA8F59Q53474990-C87A5401-A22A-49EB-BCDB-06D824186B1CQ54162899-61B1991E-41BB-4484-AC04-B2F75129B245Q55145107-A5959F05-A1EC-4882-8A25-E5F583446321Q55262530-C59D4C5B-6C8A-44D7-AE1B-E4665BCBBEF9Q57491309-504FF9B6-24E5-4ADA-B19D-5FA1E501C85FQ58762813-DFDEA05A-19FB-480C-AD26-84ACDAFD0D73
P2860
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
@en
type
label
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
@en
prefLabel
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
@en
P2093
P2860
P356
P1476
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
@en
P2093
P2860
P304
P356
10.7555/JBR.27.20130004
P577
2013-04-25T00:00:00Z